Jim Cramer says stubborn investors are taking the ‘wrong approach’ to the market

Jim Cramer says stubborn investors are taking the ‘wrong approach’ to the market


CNBC’s Jim Cramer on Tuesday warned investors not to be so set in their ways that they miss the chance to make money.

“The level of negativity about stocks at this moment is the highest it’s been in years. … There’s a new class of investors who buy stocks not based on fundamentals, but based on anger, like they’re trying to win some sort of argument. That’s the wrong approach,” the “Mad Money” host said.

“Changing your mind is a virtue in this business,” he added.

Stocks rallied on Tuesday, with the benchmark S&P 500, Nasdaq Composite and Dow Jones Industrial Average closing above their 50-day moving averages for the first time since April. 

Investors believe that the market could be bottoming after its deep downturn this year, fueled by climbing inflation, the Federal Reserve’s series of interest rate increases, the Russia-Ukraine war and Covid lockdowns in China.

Cramer echoed his reminder from earlier this month not to get too fearful over the market’s declines, and added that pessimism didn’t get him anywhere in past financial and economic crises.

“With the benefit of hindsight, my biggest mistake in each case was that I wasn’t bullish enough,” he said.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More